Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdV-tk + Valacyclovir Gene Therapy in High-Risk Prostate Cancer
NCT03541928Phase 2Unknown
- Sponsor
- Houston Methodist Research Institute
- Start
- Aug 2018
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial of adenovirus RSV-TK in prostate cancer (PCa), sponsored by Houston Methodist Research Institute. Status: unknown.
02
Drugs
adenovirus RSV-TK
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03541928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03541928.